Federal award
KBR WYLE SERVICES, LLC
0191
Contract
Obligated and Ceiling
- Obligated (net)
- $22,958,198.25
- Ceiling (potential value, not spending)
- $24,789,288.00
- Current value
- $24,789,288.00
- Gross positive obligations
- $24,718,363.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0191
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 42 · Aug 4, 2011 to Dec 2, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History42
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 2, 2019 | FY2020 | 1H | C | −$289,942.00 | |
| Oct 15, 2019 | FY2020 | 1G | C | −$386,050.88 | |
| Oct 2, 2019 | FY2020 | 1F | M | $0.00 | |
| Aug 29, 2019 | FY2019 | 1E | C | −$191,846.65 | |
| Mar 27, 2019 | FY2019 | 1D | C | −$10,445.71 | |
| Feb 21, 2018 | FY2018 | 1C | C | −$627,589.30 | |
| Oct 31, 2017 | FY2018 | 1B | C | −$143,676.43 | |
| Sep 26, 2017 | FY2017 | 1A | C | −$110,613.78 | |
| Jun 9, 2016 | FY2016 | 33 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 25, 2016 | FY2016 | 32 | C | $14,750.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 26, 2016 | FY2016 | 31 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 2, 2015 | FY2015 | 30 | C | $1,884,980.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 7, 2015 | FY2015 | 29 | C | $1,439,532.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 7, 2015 | FY2015 | 28 | C | $625,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 28, 2015 | FY2015 | 27 | C | $146,344.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 17, 2015 | FY2015 | 26 | C | $180,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 1, 2014 | FY2014 | 25 | C | $619,874.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 20, 2014 | FY2014 | 24 | C | $652,500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 8, 2014 | FY2014 | 23 | C | $313,414.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 26, 2014 | FY2014 | 22 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 15, 2014 | FY2014 | 21 | C | $250,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 25, 2013 | FY2013 | 20 | C | $2,322,500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 11, 2013 | FY2013 | 19 | C | $2,489,860.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 16, 2013 | FY2013 | 18 | C | $150,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 1, 2013 | FY2013 | 17 | C | $764,050.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 19, 2013 | FY2013 | 16 | C | $355,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 25, 2013 | FY2013 | 15 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 17, 2013 | FY2013 | 14 | C | $99,800.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 1, 2013 | FY2013 | 13 | C | $572,378.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 27, 2013 | FY2013 | 12 | C | $649,449.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 23, 2012 | FY2012 | 11 | C | $2,035,148.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 17, 2012 | FY2012 | 10 | C | $131,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 7, 2012 | FY2012 | 9 | C | $568,451.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 2, 2012 | FY2012 | 8 | C | $24,750.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 16, 2012 | FY2012 | 7 | C | $500,873.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 16, 2012 | FY2012 | 6 | C | $663,357.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 8, 2012 | FY2012 | 5 | C | $1,256,091.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 8, 2012 | FY2012 | 4 | C | $3,376,365.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 16, 2012 | FY2012 | 3 | C | $595,829.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 22, 2011 | FY2011 | 2 | C | $130,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 7, 2011 | FY2011 | 1 | C | $769,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 4, 2011 | FY2011 | 0 | — | $1,138,068.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.